TYAN
22.6.2020 17:02:12 CEST | Business Wire | Press release
TYAN® , an industry-leading server platform design manufacturer and a MiTAC Computing Technology Corporation subsidiary, is showcasing its latest lineup of HPC, storage, cloud and embedded platforms powered by 2nd Gen AMD EPYC™ 7002 series processors and 2nd Gen Intel® Xeon® Scalable Processors at TYAN server solutions online exhibition .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200622005042/en/
“With over 30 years of experience offering state-of-the-art server platforms and server motherboards, TYAN has been recognized by large scale data center customers and server channels,” said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's TYAN Business Unit. “Combining the latest innovation from our partners, like Intel and AMD, TYAN customers enable to win the market opportunities precisely with TYAN’s server building block offerings.”
Attendees will experience featured products showcase, webinar sessions and live Q & A during the virtual environment. Heading TYAN’s latest server offerings for the HPC community are Thunder HX FT83-B7119 and Transport HX TS75-B8252 . The FT83-B7119 is built around 2nd Gen Intel Xeon Scalable processors featuring ten double-width PCIe x16 slots for GPUs and 12 hot-swap, tool-less 3.5” drive bays which support up to 4 NVMe U.2 drives in a 4U enclosure. The system is ideal for AI training and inference applications. Powered by 2nd Gen AMD EPYC 7002 series processors, the TS75-B8252 is optimized for virtualization, AI inference and in-memory computing workloads. The 2U server platform features 32 DIMM slots, up to 9 PCIe 4.0 slots, 12 hot-swap, tool-less 3.5” drive bays which support up to 4 NVMe U.2 drives.
Optimized for the challenges facing in Cloud Server Providers, TYAN’s cloud platforms offer outstanding computing density and storage performance in a cost-efficient way. The new 1U Thunder SX GT93-B7106 supports dual socket 2nd Gen Intel Xeon Scalable processors with twelve 3.5” and one 2.5” easy-swap drive bays for software-defined cold storage applications. Featuring 2nd Gen AMD EPYC 7002 series processors, the Transport CX GC68-B8036 accommodates four 3.5” and four 2.5” hot-swap, tool-less drive bays in 1U for both data storage and application cache requirement in data center deployment; the Transport CX TN73-B8037-X4S is a 2U 4-node high-density server platform with support for 16 hot-swap, tool-less 2.5” drive bays supporting both NVMe U.2 and SATA devices. The system is ideal for high IOPs server use cases in data centers.
TYAN offers a full line of storage servers capable of storing massive amounts of data, ranging from 1U high-performance storage server with 12 all-flash drive bays, 2U hybrid storage server to enormous 4U high capacity 100-drive high capacity one. TYAN storage server product line provides a variety of selection for tiered storage requirements in enterprises and data centers.
Please click here for more information and to register.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200622005042/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
Digital Reef Signs Offtake Agreement with Oreasoc Agriculture to Mitigate the Environmental Footprint of Data Centre Growth Through Rainforest Protection, Appointing Xange.com as Digital MRV Partner25.9.2026 21:19:00 CEST | Press release
The offtake agreement connects Digital Reef’s 3.3 GW data centre pipeline with environmental assets from more than 30 million hectares of Amazon rainforest across South America, where Oreasoc Agriculture works directly on the ground alongside local communities to develop sustainable economies and safeguard their territories. Xange.com’s digital MRV technology monitors both the data centres and the rainforest. At Climate Week NYC, Digital Reef and Oreasoc Agriculture Inc. sign an offtake agreement connecting Digital Reef’s 3.3 GW data centre pipeline with environmental assets exceeding 30 million hectares of South American Amazon rainforest, mitigating the environmental footprint of data centre growth through rainforest protection and restoration where Oreasoc works alongside local communities to protect biodiversity, develop sustainable economies and safeguard their territories. Xange.com are appointed as digital MRV technology partner to monitor the data centres and rainforest where D
NetApp Announces Intent to Acquire PEAK:AIO to Advance Scalable AI Infrastructure Architecture25.9.2026 15:00:00 CEST | Press release
Planned acquisition strengthens NetApp's position in the rapidly growing AI infrastructure market by bringing differentiated metadata innovation and parallel file architecture designed for AI NetApp® (NASDAQ: NTAP), the intelligent data infrastructure company, today announced its intent to acquire PEAK:AIO, a pioneer in next-generation metadata architecture and high-performance parallel file systems. The planned acquisition is expected to accelerate NetApp's AI infrastructure roadmap by augmenting metadata services and parallel namespace innovation designed to help AI clouds scale shared storage alongside growing GPU clusters. As AI becomes embedded in every enterprise workload, organizations are confronting a new challenge: traditional storage architectures were not designed for the unprecedented scale, concurrency, and performance requirements of AI factories, AI clouds, and next-generation data-intensive applications. NetApp is building an architecture that disaggregates metadata fr
MultiBank Group Secures Two Awards at Forex Expo Dubai 202625.9.2026 14:57:00 CEST | Press release
The Group was recognised for the strength of its global institutional ecosystem and its contribution to financial markets innovation and community impact MultiBank Group, one of the world’s largest financial derivatives institutions, received two awards during its participation at Forex Expo Dubai 2026, held on 22 and 23 September at Dubai World Trade Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925539591/en/ MultiBank Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The Group was named “Best Global Institutional Financial Ecosystem of the Year” and received the award for “Excellence in Global Financial Markets Innovation and Community Impact.” The first award recognised the strength and breadth of MultiBank Group’s global institutional offering, which brings together trading, liquidity
Croma-Pharma Introduces saypha® volume prime Lidocaine25.9.2026 14:04:00 CEST | Press release
New cross-linked hyaluronic acid filler replaces saypha® volume Lidocaine, offering physicians a more versatile solution for both midface volumization and nasolabial folds Croma-Pharma introduces saypha® volume prime Lidocaine, a cross-linked hyaluronic acid dermal filler that replaces saypha® volume Lidocaine within the company's saypha® portfolio. The new product offers physicians a more versatile solution with expanded indications for both midface volumization and nasolabial folds, backed by strong clinical data. 1,2 saypha® volume prime Lidocaine demonstrated non-inferiority to comparatora in a randomized, subject- and evaluator-blinded, controlled, non-inferiority multicenter, parallel group comparison study with almost 500 patients.2 In the clinical evaluation, a high patient satisfaction highlights improved midface fullness, smoothness and contour, consistent with a rheologic profile designed to provide volumization in the mobile midface.b,2 With saypha® volume prime Lidocaine,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom